Medicyte, Reinnervate to develop next generation predictive 3D cell toxicity assays
Will work together to combine their upcyte and Alvetex Scaffold technologies
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Microbiota and the gut brain axis: When microbiology meets neurosciences
Scientists from around the world invited by Lallemand to its Second Scientific Exchange on the Gut-Brain Axis shared their latest…
FSSA and the emerging OTC landscape
Anil Khanna, an independent strategic consultant and investment banker, talks about FSSA guidelines and its implications OTC drugs…
Regulatory woes of pharma SMEs
Jagmohan Rai Agarwal, after elucidating about the regulatory woes of the Indian pharmaceutical industry in the last issue, draws…
Zydus Urosciences launches Udenafil
The inhibitor has been launched for the first time in India to cure erectile dysfunction
Canada-India Business Council signs MoU with Gujarat govt
To focus on sectors like pharmaceuticals, telecom, energy and finance
Novartis Q2 results enhance future growth prospects
Achieves eight significant regulatory milestones in the same quarter
CMC Machinery receives Export Excellence Award
Award recognises the company's engineering excellence combined with consistent track record in exports
Integrated Cure
Though allopathy and alternative medicine have their own strengths and limitations, an integrated approach brings the best of both…
Serum Institute of India buys Bilthoven Biologicals
Serum Institute of India, the flagship company of Poonawalla Group and India’s largest vaccine company, has acquired Bilthoven…
”We intend to build the HiOwna brand into a Rs 100-crore business”
Recently, the Himalaya Drug Company launched 'HiOwna-Jr' flagging its entry into the nutraceutical and dietary supplement market.…
SC hearing of Novartis patent case re-scheduled for August 22
Postponement due to a request from lawyers representing Novartis
AIOCD to support market-based pricing formula based on all-brands
Likely to address patient needs and balance industry growth
Astrazeneca and Cellworks collaborate to find new treatment for tuberculosis
It will pave the way for the creation of platforms and approaches to handle Multi Drug Resistant Tuberculosis
Mylan confirms first-to-file patent challenge relating to Pristique tablets
Pfizer, Wyeth, Wyeth Pharmaceuticals, and PF Prism CV sues Mylan
Natco Pharma and Mylan to appeal against US court ruling on Teva’s Copaxone
The decision by the US court covers several patents for the chemical composition of Copaxone
Provepharm signs three new distribution agreements in Europe
Agreement will cover eight additional European countries
Pharma M&A activity witnesses significant decline in volume
Asia Pacific sees highest fall in M&A activity in volume terms in June 2012, according to the Datamonitor-MedTRACK database…